A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/16 (2006.01)
Patent
CA 2533887
Pharmaceutical formulations and methods are provided for the sustained delivery of a pharmaceutical agent to a patient by injection, by oral administration or by topical administration. The injectable formulation includes porous microparticles which comprise a pharmaceutical agent and a matrix material, wherein upon injection of the formulation a therapeutically or prophylactically effective amount of the pharmaceutical agent is released from the microparticles for at least 24 hours. The oral formulation includes porous microparticles which comprise a pharmaceutical agent and a matrix material, wherein a therapeutically or prophylactically effective amount of the pharmaceutical agent is released from the microparticles for at least 2 hours following oral administration. The topical formulation includes porous microparticles which comprise a pharmaceutical agent and a matrix material, wherein a therapeutically or prophylactically effective amount of the pharmaceutical agent is released from the microparticles for at least 2 hours following topical administration.
L'invention concerne des formulations pharmaceutiques et des méthodes pour l'administration à effet prolongé d'un agent pharmaceutique à un patient par injection, ou bien par voie orale ou topique. La formulation injectable comporte des microparticules poreuses contenant un agent pharmaceutique et une matrice. Après injection de la formulation, une quantité thérapeutiquement ou prophylactiquement efficace de l'agent pharmaceutique est libérée des microparticules pendant au moins 24 heures. La formulation orale comprend des microparticules poreuses contenant un agent pharmaceutique et une matrice, une quantité thérapeutiquement ou prophylactiquement efficace de l'agent pharmaceutique étant libérée des microparticules pendant au moins 2 heures après la prise par voie orale. La formulation topique comprend des microparticules poreuses contenant un agent pharmaceutique et une matrice, une quantité thérapeutiquement ou prophylactiquement efficace de l'agent pharmaceutique étant libérée des microparticules pendant au moins 2 heures après la prise par voie topique.
Bernstein Howard
Chickering Donald E. III
Huang Eric K.
Narasimhan Sridhar
Reese Shaina
Acusphere Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Injectable, oral, or topical sustained release... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable, oral, or topical sustained release..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable, oral, or topical sustained release... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1460671